Tumour surveillance imaging in patients with extrapituitary tumours receiving growth hormone replacement

Clinical Endocrinology

Volumn 63, Issue 3, 2005, Pages 274-279

  Chung, T T ^a   Drake, W M ^a   Evanson, J ^a   Walker, D ^a   Plowman, P N ^a   Chew, S L ^a   Grossman, A B ^a   Besser, G M ^a   Monson, J P ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE;

ADENOHYPOPHYSIS; ADULT; ARTICLE; CANCER EPIDEMIOLOGY; CANCER RECURRENCE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CRANIOPHARYNGIOMA; FEMALE; FOLLOW UP; GERM CELL TUMOR; GLIOMA; HORMONE SUBSTITUTION; HUMAN; HYPOPHYSIS TUMOR; MALE; MENINGIOMA; MESENCHYMOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; TUMOR VOLUME;

ADULT; BRAIN; BRAIN NEOPLASMS; COMBINED MODALITY THERAPY; CRANIOPHARYNGIOMA; FEMALE; FOLLOW-UP STUDIES; GERMINOMA; GLIOMA; GROWTH HORMONE; HORMONE REPLACEMENT THERAPY; HUMANS; HYPOPITUITARISM; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PITUITARY IRRADIATION;

EID: 24144480877     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2005.02338.x     Document Type: Article

References (16)

1. Jorgensen, J.O.L., Pedersen, S.A., Thuesen, L., Jorgensen, J., Ingemann-Hansen, T., Skakkabaek, N. & Christiansen, J.S. (1989) Beneficial effects of growth hormone treatment in GH-deficient adults. Lancet, 1, 1221-1225.
2. Salomon, F., Cuneo, R.C., Hesp, R. & Sonksen, P.H. (1989) The effect of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. New England Journal of Medicine, 321, 1797-1803.
3. Carroll, P.V., Christ, E.R., Bengtsson, B.A., Carlsson, L., Christiansen, J.S., Clemmons, D., Hintz, R., Ho, K., Laron, Z., Sizonenko, P., Sonksen, P.H., Tanaka, T. & Thorner, M. (1998) Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review. Journal of Clinical Endocrinology and Metabolism, 83, 382-395.
4. Drake, W.M., Coyte, D., Camacho-Hubner, C., Jivanji, N.M., Kaltsas, G., Wood, D.F., Trainer, P.J., Grossman, Besser, G.M. & Monson, J.P. (1998) Optimizing growth hormone replacement therapy by dose titration in hypopituitary adults. Journal of Clinical Endocrinology and Metabolism, 83, 3913-3919.
5. Drake, W.M., Howell, S.J., Monson, J.P. & Shalet, S.M. (2001) Optimizing GH therapy in adults and children. Endocrine Review of, 22, 425-450.
6. Frajese, G., Drake, W.M., Loureiro, R.A., Evanson, J., Coyte, D., Wood, D.F., Grossman, A.B., Besser, G.M. & Monson, J.P. (2001) Hypothalamo-pituitary surveillance imaging in hypopituitary patients receiving long-term GH replacement therapy. Journal of Clinical Endocrinology and Metabolism, 86, 5172-5175.
7. Swerdlow, A.J., Reddingius, R.E., Higgins, C.D., Spoudeas, H.A., Phipps, K., Qiao, Z., Ryder, D.J., Brada, M., Hayward, R.D., Brook, C.G.D., Hindmarsh, P.C. & Shalet, S.M. (2000) Growth hormone treatment of children with brain tumors and risk of tumor recurrence. Clinical Endocrinology, 85, 4444-4449.
8. Janmohamed, S., Grossman, A.B., Metcalfe, K., Lowe, D.G., Wood, D.F., Chew, S.L., Monson, J.P., Besser, G.M. & Plowman, P.N. (2002) Suprasellar germ cell tumours: specific problems and the evolution of optimal management with a combined chemoradiotherapy regimen. Clinical Endocrinology, 57, 467-500.
9. Matsutani, M., Sano, K., Takakura, K., Fujimaki, T., Nakamura, O., Funata, N. & Seto, T. (1997) Primary intracranial germ cell tumors: a clinical analysis of 153 histologically verified cases. Journal of Neurosurgery, 86, 446-455.
10. Kiltie, A.E., Collins, C.D., Gattamaneni, H.R. & Shalet, S.M. (1997) Relapse of intracranial germinoma 23 years postirradiation in a patient given growth hormone replacement. Medical Pediatric Oncology, 29, 41-44.
11. Abs, R., Bengtsson, B.A., Hernberg-Stahl, E., Monson, J.P., Taber, J., Wilton, P. & Wuster, C. (1999) GH-replacement in 1037 growth hormone deficient hypopituitary adults: demographic and clinical characteristics, dosing and safety. Clinical Endocrinology, 50, 703-713.
12. Duff, J.M., Meyer, F.B., Ilstrup, D.M., Laws, E.R., Schlek, C.D. & Scheithauer, B.W. (2000) Long-term outcomes for surgically resected craniopharyngioma. Neurosurgery, 46, 291-301.
13. Bulow, B., Attewell, R., Hagmar, L., Malmstrom, P., Nordstrom, C.H. & Erfurth, E.M. (1988) Postoperative prognosis in craniopharyngioma with respect to cardiovascular mortality, survival, and tumour recurrence. Journal Clinical Endocrinology and Metabolism, 83, 3897-3904.
14. Jose, C.C., Rajan, B., Ashley, S., Marsh, H. & Brada, M. (1992) Radiotherapy for the treatment of recurrent craniopharyngioma. Clinical Oncology, 4, 287-289.
15. Karavitaki, N., Brufani, C., Warner, J.T., Adams, C.B.T., Richards, P., Ansorges, O., Shine, B., Turner, H.E. & Wass, J.A.H. (2005) Craniopharyngiomas in children and adults: systemic analysis of 121 cases with long-term follow up. Clinical Endocrinology, 62, 397-409.
16. Shin, J.L., Asa, S.L., Woodhouse, L.J., Smyth, H.S. & Ezzat, S. (1999) Cystic lesion of pituitary: clinicopathological features distinguishing craniopharyngioma, Rathke's cleft cyst, and arachnoid cyst. Journal of Clinical Endocrinology and Metabolism, 84, 3972-3982.